Updated Jul 16, 2026 · Last SEC filing 2026-07-15
BeOne Medicines Ltd. (ONC) has filed 35 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-15. 4 Form 8-K material event filings were reported by ONC in the last 90 days. 29 Form 144 notices of proposed sale were filed for ONC stock. InsiderAlpha tracks every ONC SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0001651308 |
| Form 4 filings (90d) | 35 |
|---|---|
| Form 8-K filings (90d) | 4 |
| Form 144 notices (90d) | 29 |
| Latest Form 4 filing | 2026-07-15 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| OYLER JOHN | Chief Executive Officer | S — Open-market sale [10b5-1] | 40.8K | $306.93 | $12.52M | SEC | |
| OYLER JOHN | Chief Executive Officer | S — Open-market sale [10b5-1] | 8.1K | $303.93 | $2.47M | SEC | |
| OYLER JOHN | Chief Executive Officer | S — Open-market sale [10b5-1] | 45.9K | $306.21 | $14.05M | SEC | |
| OYLER JOHN | Chief Executive Officer | M — Option exercise [10b5-1] | 36.3K | $100.04 | $3.63M | SEC | |
| OYLER JOHN | Chief Executive Officer | S — Open-market sale [10b5-1] | 7.8K | $307.57 | $2.41M | SEC | |
| OYLER JOHN | Chief Executive Officer | M — Option exercise [10b5-1] | 97.3K | $36.90 | $3.59M | SEC | |
| OYLER JOHN | Chief Executive Officer | S — Open-market sale [10b5-1] | 4.1K | $303.07 | $1.25M | SEC | |
| OYLER JOHN | Chief Executive Officer | S — Open-market sale [10b5-1] | 39.1K | $305.02 | $11.92M | SEC | |
| Lee Chan Henry | SVP, General Counsel | M — Option exercise | 202 | $194.47 | $39K | SEC | |
| Lee Chan Henry | SVP, General Counsel | M — Option exercise | 196 | $159.03 | $31K | SEC | |
| Lee Chan Henry | SVP, General Counsel | M — Option exercise | 266 | $213.32 | $57K | SEC | |
| Lee Chan Henry | SVP, General Counsel | S — Open-market sale | 664 | $302.46 | $201K | SEC | |
| Wang Lai | President, Global Head of R&D | S — Open-market sale | 1.1K | $276.74 | $296K | SEC | |
| OYLER JOHN | Chief Executive Officer | S — Open-market sale | 1.3K | $274.12 | $354K | SEC | |
| OYLER JOHN | Chief Executive Officer | S — Open-market sale | 1.8K | $273.30 | $492K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for BeOne Medicines Ltd. (ONC). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| OYLER JOHN | 24 | $55.60M |
| Lee Chan Henry | 20 | $998K |
| Wu Xiaobin | 7 | $1.28M |
| Wang Lai | 7 | $1.17M |
| BAKER BROS. ADVISORS LP | 6 | $262K |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ONC insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live ONC dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.